Lung Cancer Clinical Trials

Showing 861-880 of 2,032 trials

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

NCT02337530

The purpose of this study is to find out what effects a new drug, selumetinib, has on lung cancer when receiving standard chemotherapy with pemetrexed and platinum-based chemotherapy.

Non-Small Cell Lung Cancer

Canadian Cancer Trials Group62 participantsStarted May 2015

Calgary, Alberta, Canada • Edmonton, Alberta, Canada • Abbotsford, British Columbia, Canada +9 more locations

NOT_YET_RECRUITINGPHASE2/PHASE3

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

NCT06319313

This study is a phase II/III, randomized, controlled, open-label, multi-center study with safety run-in to evaluate the efficacy and safety of JMT101 combined with docetaxel/ HB1801 in Patients with Squamous cell non-small cell lung cancer （sqNSCLC）.

Squamous Cell Non-small Cell Lung Cancer

Shanghai JMT-Bio Inc.534 participantsStarted May 2024

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

Related Searches

High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases

Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer

Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients

T790M Plasma Testing Methodology Comparison and Clinical Validation

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

Canine-Assisted Profiling of Lung Cancer From Human Breath

Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery

AI Determine Malignancy of GGO on Chest CT

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning

Clinical Research for the Consistency Analysis of PD-L1 in Cancer Tissue and Plasma Exosome

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Lung EpiCheck Biomarkers Development Study